KKR to invest $100m in Zeus Health, a platform focused on investing in and operating a portfolio of emerging medical device companies. “We are excited to have the opportunity to work with Duke and his team again, now for the third time following our previous success with Ajax Health and Spirox. Duke is a proven leader in the medical device field, as are his team of industry and operational experts. We look forward to working together to identify and scale much-needed next-generation medical technologies,” Ali Satvat, KKR Global Head of Health Care Strategic Growth and Co-Head of Health Care within KKR’s North America Private Equity platform.